NCT05602623View on ClinicalTrials.gov

Characterizing the Intraocular Scattering at Different Wavelengths

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

May 25, 2023

Primary Completion Date

June 12, 2024

Study Completion Date

June 12, 2024

Conditions
Vision, Ocular
Interventions
DEVICE

Adaptive Optics System (AO)

Subjects will have their higher and lower order aberrations corrected with the AO system.

Trial Locations (1)

77204

University of Houston College of Optometry, Houston

All Listed Sponsors
lead

Johnson & Johnson Vision Care, Inc.

INDUSTRY

NCT05602623 - Characterizing the Intraocular Scattering at Different Wavelengths | Biotech Hunter | Biotech Hunter